ESTIMATION OF IMPURITY PROFILES OF DRUGS AND RELATED MATERIALS .9. HPLC INVESTIGATION OF FLUMECINOL

被引:12
作者
GOROG, S
HERENYI, B
RENYEI, M
机构
[1] Chemical Works G. Richter Ltd, H-1475 Budapest
关键词
IMPURITY PROFILING; HPLC; CHIRAL SEPARATION; SPECTRAL CONVOLUTION; FLUMECINOL; 4'-METHYLFLUMECINOL;
D O I
10.1016/0731-7085(91)80088-Q
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Two HPLC systems have been developed for the investigation of flumecinol (3-trifluoromethly-alpha-ethyl-benzhydrol). The reversed-phase system (LiChrosorb RP-18; methanol-water, 7:3, v/v) enables the isolation and identification of the impurities. The chiral system (Chiralcel OD; hexane-2-propanol, 98:2, v/v) separates the enantiomers of flumecinol and its impurities. The potential of spectral convolution in peak identification in HPLC impurity profiling is demonstrated by an example involving the identification of the 4'-methyl-analogue of flumecinol.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 7 条
[1]   ANALYSIS OF STEROIDS .38. THE USE OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH DIODE-ARRAY UV DETECTION FOR ESTIMATING IMPURITY PROFILES OF STEROID DRUGS [J].
GOROG, S ;
HERENYI, B .
JOURNAL OF CHROMATOGRAPHY, 1987, 400 :177-186
[2]   ALPHA-1-ACID GLYCOPROTEIN COLUMN IN THE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF SOME GROUPS OF CHIRAL DRUGS [J].
GOROG, S ;
HERENYI, B .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :837-842
[3]   ESTIMATION OF IMPURITY PROFILES IN DRUGS AND RELATED MATERIALS [J].
GOROG, S ;
LAUKO, A ;
HERENYI, B .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1988, 6 (6-8) :697-705
[4]   ANALYSIS OF STEROIDS .43. ESTIMATION OF IMPURITY PROFILES OF DRUGS AND RELATED MATERIALS .8. COMBINED APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND NMR-SPECTROSCOPY IN THE IMPURITY PROFILING OF DRUGS [J].
GOROG, S ;
BALOGH, G ;
GAZDAG, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :829-833
[5]   THE CHANGING-ROLE OF ULTRAVIOLET SPECTROSCOPY IN DRUG ANALYSIS [J].
GOROG, S ;
RENYEI, M ;
HERENYI, B .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (12) :1527-1533
[6]  
GOROG S, 1991, PHARMACON SEOUL, V21, P190
[7]  
LAUKO A, 1991, 13TH P INT S CAP CHR, V2, P1548